On Demand Recordings

8th Annual Spring to Life


May 14-15, 2021

Proudly Hosted by New York Oncology Hematology, PC




  • This is a recorded CME-Accredited On-Demand Online Activity
  • Upon registration, confirmation will be provided via email with login instructions

Next quote »

"Identification of molecular drivers has resulted in tailored treatments for our patients with non-small cell lung cancer which are not only more effective, but less toxic. It is essential the community oncologist have a keen knowledge of the most current precision testing techniques and incorporate newer therapies to provide state-of-the-art care to patients close to home."

-Makenzi Evangelist, M.D., New York Oncology Hematology

“The landscape of lung cancer with new biomarkers, immunotherapies, and targeted therapies is constantly evolving, and it is a challenge for the community oncologist to integrate and apply this new knowledge in daily clinical practice. Accessible continuing education forums are crucial to support this rapid evolution of cancer care."

-Nischala Ammannagari, M.D., New York Oncology Hematology


Please click here if you would like to be notified when registration is open. We hope to see you in 2020!
S2L | Registration HCP

Conference Platform

The 2021 Spring to Life conference was held live online utilizing a multimedia webcast and virtual conference platform to livestream the keynote, plenary sessions and ancillary events along with moderated Q&A panel discussions. The conference was recorded and will be offered on-demand for 30 days following the live conference.


New York Oncology Hematology (NYOH) has identified an ongoing unmet need for medical education in the area of hematologic malignancies. To meet this need, NYOH, in collaboration with The University of Chicago Pritzker School of Medicine, myMedEd, Inc., the American Cancer Society, the Leukemia & Lymphoma Society and a panel of expert faculty from the academic, research, and community practice settings, developed an accredited, multi-supported, 2-day educational conference.  With an expanded agenda the conference is offering 8.5-hrs of continuing medical education.  This is the eighth of these annual conferences that include programming for cancer clinicians.


The purpose of this conference is to educate practitioners and update their knowledge of the biologic pathways associated with Leukemias and the existing and emerging therapies for the management of patients with leukemia.


The target audience for this conference is the medical oncologist, hematologists, pathologists, oncology nurses, advanced practice providers, family and primary care practitioner, allied health professional, and any other individuals with an interest in the care of patients with Leukemias.


After completing this activity, participants will be able to:

  • Describe the evolving gene mutational spectrum of malignant myeloid disease and the treatment paradigms of acute myeloid leukemia in the young fit and elderly or unfit populations
  • List the advances in biologic knowledge and treatments, including non-chemotherapy based treatments for acute lymphoblastic leukemia from young adults to the elderly
  • Review the current state of allogeneic hematopoietic stem cell transplantation in the curative treatment of acute leukemias
  • Discuss the shift in knowledge and treatment decision making in chronic lymphocytic leukemia and the management of chronic myeloid leukemia, including selecting for treatment free remission
  • Explain the current knowledge on hematologic complications of COVID-19 and the data and contributors to outcomes disparities in Americans with hematologic malignancies

This Activity Is Planned By myMedEd, Inc.

Educational Partners

Accredited Provider

Accredited Provider
Educational Partner
Image Image

This Activity Is Planned By myMedEd, Inc.